Hepatobiliary Pancreat Dis Int

	2021 Vol. 20 No. 5
	Published: 15 October 2021


	Pages 409-510
	ORIGINAL ARTICLES/Liver ORIGINAL ARTICLES/Biliary ORIGINAL ARTICLES/Pancreas LETTERS TO THE EDITOR VIEWPOINTS Special issue on nonalcoholic fatty liver disease

Special issue on nonalcoholic fatty liver disease

	409	Liu YX, Liu X, Cen C, Li X, Liu JM, Ming ZY, Yu SF, Tang XF, Zhou L, Yu J, Huang KJ, Zheng SS
		Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 409-415. [Abstract] HTML (1 KB) PDF (0 KB)

	416	Chang XJ, Shi YW, Wang J, Liu HB, Chen Y, Zhu XN, Chen YP, Yu ZJ, Shang QH, Tan L, Li Q, Jiang L, Xiao GM, Chen L, Lu W, Hu XY, Long QH, An LJ, Zou ZY, Wong VWS, Yang YP, Fan JG
		Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment ^Hot!
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 416-425. [Abstract] HTML (1 KB) PDF (0 KB)

	426	Yang RX, Zou ZS, Zhong BH, Deng H, He FP, Shi JP, Zhao CY, Mi YQ, Zhou YJ, Di FS, Zheng RD, Du Q, Shang J, Popovic B, Chen J, Fan JG
		The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China ^Hot!
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 426-432. [Abstract] HTML (1 KB) PDF (0 KB)

	433	Fan GH, Wei RL, Wei XY, Zhang CZ, Qi ZT, Xie HY, Zheng SS, Xu X
		Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study ^Hot!
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 433-451. [Abstract] HTML (1 KB) PDF (0 KB)

	452	Wang ZH, Zheng KI, Wang XD, Qiao J, Li YY, Zhang L, Zheng MH, Wu J
		LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 452-459. [Abstract] HTML (1 KB) PDF (0 KB)

ORIGINAL ARTICLES/Liver

	460	Zhou QH, Hu CQ, Shi Y, Wu FT, Yang Q, Guan J, Li AC, Chen Z
		Cryptococcosis in patients with liver cirrhosis: Death risk factors and predictive value of prognostic models
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 460-468. [Abstract] HTML (1 KB) PDF (0 KB)

	469	Gu YL, Xiao LL, Li DJ, Liu YN, Zhu CJ, Zhang SJ
		Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 469-477. [Abstract] HTML (1 KB) PDF (0 KB)

ORIGINAL ARTICLES/Biliary

	478	Chon HK, Park C, Park DE, Kim TH
		Efficacy and safety of conversion of percutaneous cholecystostomy to endoscopic transpapillary gallbladder stenting in high-risk surgical patients
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 478-484. [Abstract] HTML (1 KB) PDF (0 KB)

ORIGINAL ARTICLES/Pancreas

	485	Busquets J, Lopez-Dominguez J, Gonzalez-Castillo A, Vila M, Pelaez N, Secanella L, Ramos E, Fabregat J
		Pancreas sparing duodenectomy in the treatment of primary duodenal neoplasms and other situations with duodenal involvement
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 485-492. [Abstract] HTML (1 KB) PDF (0 KB)

VIEWPOINTS

	493	Eso Y, Seno H
		Synergistic effects of anti-angiogenesis and immune checkpoint blockade - a new era of systemic chemotherapy for hepatocellular carcinoma
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 493-495. [Abstract] HTML (1 KB) PDF (0 KB)

	496	Wang KC, Wang ZG, Dai YB, Wu HF, Yi DH
		Bioinformatics: A beacon of hope in identifying molecular target
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 496-498. [Abstract] HTML (1 KB) PDF (0 KB)

	499	Chen ZR, Jin SF, Ma WB, Jiang RL
		Intestinal microecology: A crucial strategy for targeted therapy of liver diseases
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 499-500. [Abstract] HTML (1 KB) PDF (0 KB)

	501	Xu YW, Fu H
		Application of intraoperative ultrasound in liver surgery
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 501-502. [Abstract] HTML (1 KB) PDF (0 KB)

LETTERS TO THE EDITOR

	503	Bonaccorsi-Riani E, Gillooly A, Bruggenwirth IMA, Martins PN
		Delivery of genetic load during ex situ liver machine perfusion with potential for CRISPR-Cas9 gene editing: An innovative strategy for graft treatment
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 503-505. [Abstract] HTML (1 KB) PDF (0 KB)

	506	Rizzo A, Ricci AD, Brandi G
		Combination therapy of dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 506-507. [Abstract] HTML (1 KB) PDF (0 KB)

	508	Sun HY, Tong HJ, Cui DW
		Acute hepatitis associated with increased atypical lymphocyte
		Hepatobiliary Pancreat Dis Int. 2021; 20(5): 508-510. [Abstract] HTML (1 KB) PDF (0 KB)

Forgot your password?

Enter your e-mail address to receive an e-mail with your account information.

Submission Guidance

Top cited articles

- Most Cited Hepatobiliary & Pancreatic Diseases International Articles

- Most Downloaded Hepatobiliary & Pancreatic Diseases International Articles

more>>

Top downloaded articles

more>>

Services

Web feed

hbpdint@126.com

hbpdje@zju.edu.cn

Copyright © Official Publication of First Affiliated Hospital
Official Publication of First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
浙ICP备05050873号-1